Conference Proceedings

OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC

B Solomon, P Kok, A Livingstone, S Yip, C Brown, S Dawson, S Wong, N Pavlakis, M Stockler

JOURNAL OF THORACIC ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2017

DOI: 10.1016/j.jtho.2017.09.1295

University of Melbourne Researchers

Citation metrics

2Dimensions

Keywords

Osimertinib
3202 Clinical Sciences
Lung
Clinical Research
Life Sciences & Biomedicine
32 Biomedical and Clinical Sciences
3211 Oncology and Carcinogenesis
T790m
Egfr
Science & Technology
Oncology
Clinical Trials and Supportive Activities
Respiratory System